30 Day Trial

BARE BONES content is posted to these pages in real time.

Monthly compilations are available in PDF form.

Reimbursement / Regulatory

Episurf Medical Receives Expanded Reimbursement Coverage in the EU -

Episurf Medical's Episealer® procedure and products are approved for payment by the U.K. Spire Hospitals and the Dutch health insurance companies, VGZ and Multiorg. 

Further, the Belgium reimbursement authority RIZIV (The National Institute for Health and Disability Insurance) approved the Episealer Femoral Twin implant, thus clearning the entire portfolio (Condyle Solo, Trochlea Solo and Femoral Twin) for payment by the Belgium authority.

This activity supports Episurf's plan to achieve private health sector reimbursement. Episurf's patient-specific implants and Epiguide® drill guides are designed to treat localized cartilage injury in joints. 

Source: Episurf Medical AB

Episurf is prepping for U.S. market entry. Experien Group has recommended a pre-510(k) submission meeting with FDA to discuss their technology, proposed indications for use and proposed performance testing.

This article is a Member-only item of content. Members, please log in to read the complete post.
If you are not yet a Member, click here to learn more about purchasing ORTHOWORLD Membership.